OUR MISSION is to serve pharmaceutical clients that provide cures and treatments for gastro-entrological diseases including: gallstones, PBC, PSC and NASH.
News
ICE acquires Mitsubishi APIC’s Iwaki UDCA Plant
ICE Group, a global niche active pharmaceutical ingredient (“API”) and specialty ingredients company, is proud to announce its agreement on the definitive terms to acquire the Iwaki Ursodeoxycholic Acid (“UDCA”) manufacturing site from Mitsubishi API Corporation.
ICE Group - Vaccination Hub in Basaluzzo, Italy.
We’re glad to announce that starting from the 3rd of June 2021, in line with our commitment to sustain our territory, in particular during the fight against COVID-19, ICE has officially opened its own Vaccination HUB.
World Water Day - 22 March 2021
Water is the most precious and essential good for life, that’s why it should be preserved avoiding any kind of waste. ICE Group has committed itself to enhance the sustainability of its production process, and thus has worked a lot on improving its internal water cycle management with the specific…
ABOUT ICE GROUP
ICE Group is a globally integrated business that produces ingredients for the pharmaceutical industry. Our main product is Ursodeoxycholic Acid (UDCA), a key ingredient in drugs treating liver conditions.
Founded more than sixty years ago, ICE Group is a global leader in bile-related products, with a network of specialist facilities around the world.
-
1949
ICE’s first plant was opened in Reggio Emilia, Italy (production of Cholic Acid and bile acids derivatives)
-
1996
BBA Industria Quimica (former Opoterapica) founded in Paranà, Brazil (collection of ox bile and its transformation in raw Cholic Acid)
-
1999
Acquisition of RPT Texas, USA (collection and concentration of ox bile)
-
2003
Opening of Arennis in Argentina (collection and concentration of ox bile)
-
2004
Opening of Walfed Pty in Australia (collection and concentration of ox bile)
-
2008
Acquisition of PCA, a major manufacturer of UDCA and derivative in Italy
Opening of PBP in Paraguay (collection and concentration of ox bile) -
2010
Opening of CVF in Uruguay (collection and concentration of ox bile)
-
2014
Opening of the Des Moines plant in the USA (collection and concentration of pig bile)
-
2015
Acquisition of RIAZ in Italy (collection and concentration of ox bile and pig bile)
-
2016
Opening of Raichem (a 50% Joint Venture started in India)
-
2018
Raichem becomes a fully owned subsidiary
-
2019
Advent International acquires ICE Group
OUR HISTORY
ICE Group was established in 1949 by husband-and-wife team Dr Walter and Ida Bartoli. From our humble origins in Northern Italy, we have grown organically and through acquisitions into the company we are today.
Our Footprint
We have a vertically integrated model from sourcing to pharma grade production.
BILE
COLLECTION
Europe, US, Latin America, South
Africa, India, Australia
CHOLIC ACID
PRODUCTION
Brazil
API
PRODUCTION
Italy, New Zealand, India
Our facilities
As well as being the number-one player in the manufacture of UDCA, we also produce a comprehensive range of bile acid derivatives as well as other products we have developed.
Production plants, Italy
Production plant, New Zealand
Bile extraction plant
and Cholic Acid
production,
Brazil
Production plant, India
Custom Carbohydrate Synthesis & Manufacture, UK
Processing plant, Piacenza, Italy
Processing plants in, Texas & Iowa, USA
Bile extraction plants, Agentina, Uruguay & Paraguay
Our values
QUALITY IN
EVERYTHING
WE DO
SAFETY
ABOVE ALL
TREAT
EVERYBODY
WITH RESPECT
innovation
FOR OUR
CLIENTS AND
PATIENTS